Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 285

1.

Psychosocial risk and protective factors associated with perpetration of gender-based violence in a community sample of men in rural KwaZulu-Natal, South Africa.

Mngoma N, Fergus S, Jeeves A, Jolly R.

S Afr Med J. 2016 Dec 1;106(12):1211-1215. doi: 10.7196/SAMJ.2016.v106.i12.11233.

PMID:
27917766
2.

Slow, continuous enzyme replacement via spinal CSF in dogs with the paediatric-onset neurodegenerative disease, MPS IIIA.

King B, Marshall NR, Hassiotis S, Trim PJ, Tucker J, Hattersley K, Snel MF, Jolly RD, Hopwood JJ, Hemsley KM.

J Inherit Metab Dis. 2016 Nov 10. [Epub ahead of print]

PMID:
27832416
3.

Nano-hydroxyapatite/β-CD/chitosan nanocomposite for potential applications in bone tissue engineering.

Shakir M, Jolly R, Khan MS, Rauf A, Kazmi S.

Int J Biol Macromol. 2016 Dec;93(Pt A):276-289. doi: 10.1016/j.ijbiomac.2016.08.046.

PMID:
27543347
5.

A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations.

Hayes EP, Jolly RA, Faria EC, Barle EL, Bercu JP, Molnar LR, Naumann BD, Olson MJ, Pecquet AM, Sandhu R, Shipp BK, Sussman RG, Weideman PA.

Regul Toxicol Pharmacol. 2016 Aug;79 Suppl 1:S39-47. doi: 10.1016/j.yrtph.2016.06.001. Review.

PMID:
27267172
6.

Issues and approaches for ensuring effective communication on acceptable daily exposure (ADE) values applied to pharmaceutical cleaning.

Olson MJ, Faria EC, Hayes EP, Jolly RA, Barle EL, Molnar LR, Naumann BD, Pecquet AM, Shipp BK, Sussman RG, Weideman PA.

Regul Toxicol Pharmacol. 2016 Aug;79 Suppl 1:S19-27. doi: 10.1016/j.yrtph.2016.05.024. Review.

PMID:
27233923
7.

Assessing Concordance of Drug-Induced Transcriptional Response in Rodent Liver and Cultured Hepatocytes.

Sutherland JJ, Jolly RA, Goldstein KM, Stevens JL.

PLoS Comput Biol. 2016 Mar 30;12(3):e1004847. doi: 10.1371/journal.pcbi.1004847.

8.

Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.

Ahlberg E, Amberg A, Beilke LD, Bower D, Cross KP, Custer L, Ford KA, Van Gompel J, Harvey J, Honma M, Jolly R, Joossens E, Kemper RA, Kenyon M, Kruhlak N, Kuhnke L, Leavitt P, Naven R, Neilan C, Quigley DP, Shuey D, Spirkl HP, Stavitskaya L, Teasdale A, White A, Wichard J, Zwickl C, Myatt GJ.

Regul Toxicol Pharmacol. 2016 Jun;77:1-12. doi: 10.1016/j.yrtph.2016.02.003.

PMID:
26879463
9.

Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.

Amberg A, Beilke L, Bercu J, Bower D, Brigo A, Cross KP, Custer L, Dobo K, Dowdy E, Ford KA, Glowienke S, Van Gompel J, Harvey J, Hasselgren C, Honma M, Jolly R, Kemper R, Kenyon M, Kruhlak N, Leavitt P, Miller S, Muster W, Nicolette J, Plaper A, Powley M, Quigley DP, Reddy MV, Spirkl HP, Stavitskaya L, Teasdale A, Weiner S, Welch DS, White A, Wichard J, Myatt GJ.

Regul Toxicol Pharmacol. 2016 Jun;77:13-24. doi: 10.1016/j.yrtph.2016.02.004.

10.

It's difficult, but important, to make negative predictions.

Williams RV, Amberg A, Brigo A, Coquin L, Giddings A, Glowienke S, Greene N, Jolly R, Kemper R, O'Leary-Steele C, Parenty A, Spirkl HP, Stalford SA, Weiner SK, Wichard J.

Regul Toxicol Pharmacol. 2016 Apr;76:79-86. doi: 10.1016/j.yrtph.2016.01.008.

PMID:
26785392
11.

Animal medical genetics: a perspective on the epidemiology and control of inherited disorders.

Jolly RD, Dittmer KE, Blair HT.

N Z Vet J. 2016 May;64(3):135-44. doi: 10.1080/00480169.2015.1129296. Review.

PMID:
26667890
12.

Effect of alteplase on the CT hyperdense artery sign and outcome after ischemic stroke.

Mair G, von Kummer R, Morris Z, von Heijne A, Bradey N, Cala L, Peeters A, Farrall AJ, Adami A, Potter G, Cohen G, Sandercock PA, Lindley RI, Wardlaw JM; IST-3 Collaborative Group..

Neurology. 2016 Jan 12;86(2):118-25. doi: 10.1212/WNL.0000000000002236.

13.

The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness.

Dennis M, Sandercock P, Graham C, Forbes J; CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration., Smith J.

Health Technol Assess. 2015 Sep;19(76):1-90. doi: 10.3310/hta19760.

14.

Interaction mode of polycarbazole-titanium dioxide nanocomposite with DNA: Molecular docking simulation and in-vitro antimicrobial study.

Iram NE, Khan MS, Jolly R, Arshad M, Alam M, Alam P, Khan RH, Firdaus F.

J Photochem Photobiol B. 2015 Dec;153:20-32. doi: 10.1016/j.jphotobiol.2015.09.001.

PMID:
26386641
15.

Stigma, HIV and health: a qualitative synthesis.

Chambers LA, Rueda S, Baker DN, Wilson MG, Deutsch R, Raeifar E, Rourke SB; Stigma Review Team..

BMC Public Health. 2015 Sep 3;15:848. doi: 10.1186/s12889-015-2197-0. Review.

16.

Nano-hydroxyapatite/chitosan-starch nanocomposite as a novel bone construct: Synthesis and in vitro studies.

Shakir M, Jolly R, Khan MS, Iram Ne, Khan HM.

Int J Biol Macromol. 2015 Sep;80:282-92. doi: 10.1016/j.ijbiomac.2015.05.009.

PMID:
26116779
17.

An evaluation of in-house and off-the-shelf in silico models: implications on guidance for mutagenicity assessment.

Jolly R, Ahmed KB, Zwickl C, Watson I, Gombar V.

Regul Toxicol Pharmacol. 2015 Apr;71(3):388-97. doi: 10.1016/j.yrtph.2015.01.010.

PMID:
25656493
18.

Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content.

Kaur S, Srivastava G, Sharma AN, Jolly RS.

Br J Pharmacol. 2015 May;172(9):2286-99. doi: 10.1111/bph.13051.

19.

Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.

ENOS Trial Investigators., Bath PM, Woodhouse L, Scutt P, Krishnan K, Wardlaw JM, Bereczki D, Sprigg N, Berge E, Beridze M, Caso V, Chen C, Christensen H, Collins R, El Etribi A, Laska AC, Lees KR, Ozturk S, Phillips S, Pocock S, de Silva HA, Szatmari S, Utton S.

Lancet. 2015 Feb 14;385(9968):617-28. doi: 10.1016/S0140-6736(14)61121-1. Erratum in: Lancet. 2015 Feb 14;385(9968):606.

20.

Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: secondary analyses from CLOTS 3, a randomised trial.

CLOTS (Clots in Legs Or sTockings after Stroke) Trials Collaboration..

Lancet Neurol. 2014 Dec;13(12):1186-92. doi: 10.1016/S1474-4422(14)70258-3.

Supplemental Content

Loading ...
Support Center